Keywords: viramune, mtct, study, arm, stopped, early, risk

Viramune MTCT study has arm stopped early

Article | 22 July 2002

Print This

The risk of a mother transmitting HIV to her newborn is significantlyreduced when Boehringer Ingelheim's Viramune (nevirapine) is added to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in